Relay Therapeutics Growth Metrics (2020-2025) | RLAY

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -73.98M42.75M-1.23M0.11M-1.58M-1.34M-2.29M-6.12M2.46M805.60M3.88M-0.02M
EBITDA Margin Growth (3y) -73.09M847.00M0.36M1.58M1.13M
EBITDA Margin (QoQ) -117.02M43.51M-1.85M1.38M-0.30M-0.47M-0.50M-0.31M-0.06M-1.41M-4.34M8.28M803.08M-803.13M-0.94M
EBIT Margin Growth (1y) -74.13M42.54M-1.05M0.16M-1.58M-1.69M-2.98M-6.78M2.47M924.84M4.39M-0.02M
EBIT Margin Growth (3y) -73.24M965.70M0.36M1.39M1.00M
EBIT Margin (QoQ) -116.95M43.29M-1.85M1.38M-0.28M-0.30M-0.63M-0.37M-0.38M-1.60M-4.43M8.88M921.99M-922.05M-1.02M
EBT Margin Growth (1y) -73.07M42.91M-1.04M0.19M-1.53M-1.48M-2.69M-6.17M2.42M837.63M4.09M-0.02M
EBT Margin Growth (3y) -72.18M879.05M0.36M1.38M1.07M
EBT Margin (QoQ) -116.25M43.65M-1.85M1.38M-0.28M-0.29M-0.62M-0.34M-0.22M-1.50M-4.11M8.25M834.99M-835.04M-0.93M
Enterprise Value Growth (1y) 4,169.27%2,376.64%-17.68%-7.72%9.05%-45.12%-22.74%-45.54%-41.12%-19.32%-57.92%-26.65%-49.08%-47.06%-9.16%-53.41%-62.54%-34.47%1.61%
Enterprise Value Growth (3y) 204.12%129.45%-35.56%-28.30%-31.11%-38.34%-33.41%-42.91%-51.75%-34.59%-27.04%
Enterprise Value Growth (5y) 47.51%40.61%-24.40%
Enterprise Value (QoQ) -94.84%2,487.94%0.59%-13.05%9.01%-13.66%12.76%2.75%-45.14%21.56%-20.52%11.10%-24.83%-36.61%38.55%-22.87%-21.86%8.78%-28.94%-37.98%36.69%68.68%
FCF Margin Growth (1y) -49.77M-44.89M-1.73M-1.27M-1.16M-1.63M-1.81M-4.28M1.95M895.41M3.00M-0.04M
FCF Margin Growth (3y) -48.97M848.89M-0.54M1.14M0.80M
FCF Margin (QoQ) -4.77M-43.69M-0.83M-0.48M0.11M-0.52M-0.37M-0.37M-0.36M-0.71M-2.84M5.86M893.09M-893.11M-0.72M
Interest Coverage Ratio Growth (1y) 64.78%-1,029.19%
Interest Coverage Ratio (QoQ) 159.74%-293.92%
Net Margin Growth (1y) -428.65M42.91M-1.04M0.19M-1.53M-1.48M-2.69M-6.17M2.42M837.63M4.09M-0.02M
Net Margin Growth (3y) -427.76M879.05M0.36M1.38M1.07M
Net Margin (QoQ) -471.83M43.65M-1.85M1.38M-0.28M-0.29M-0.62M-0.34M-0.22M-1.50M-4.11M8.25M834.99M-835.04M-0.93M
Operating Margin Growth (1y) -74.13M42.54M-1.05M0.16M-1.58M-1.69M-2.98M-6.78M2.47M924.84M4.39M-0.02M
Operating Margin Growth (3y) -73.24M965.70M0.36M1.39M1.00M
Operating Margin (QoQ) -116.95M43.29M-1.85M1.38M-0.28M-0.30M-0.63M-0.37M-0.38M-1.60M-4.43M8.88M921.99M-922.05M-1.02M
Return on Assets Growth (1y) -31.003.009.0018.009.00-5.00-7.00-13.00-9.00-6.00-6.002.00-1.00-1.00-2.00
Return on Assets Growth (3y) -30.00-8.00-3.006.00-1.00-12.00-14.00
Return on Assets (QoQ) -23.00-6.00-6.004.0010.001.003.00-5.00-4.000.00M-4.000.00M-1.00-1.003.00-2.00-1.00-2.00
Return on Capital Employed Growth (1y) -32.002.009.0017.007.00-9.00-9.00-16.00-11.00-7.00-7.000.00M-1.000.00M-2.00
Return on Capital Employed Growth (3y) -36.00-14.00-8.001.00-5.00-16.00-18.00
Return on Capital Employed (QoQ) -24.00-6.00-5.004.0010.000.00M3.00-6.00-6.00-1.00-4.00-1.00-2.000.00M3.00-2.00-1.00-2.00
Return on Equity Growth (1y) -35.002.0011.0020.009.00-8.00-8.00-15.00-9.00-5.00-4.003.00-1.000.00M-1.00
Return on Equity Growth (3y) -35.00-10.00-2.008.000.00M-12.00-14.00
Return on Equity (QoQ) -26.00-9.00-6.005.0011.000.00M3.00-5.00-5.000.00M-4.001.00-1.000.00M4.00-3.000.00M-2.00
Return on Sales Growth (1y) 13.00-0.01M-0.01M-0.01M-0.02M0.02M0.02M0.03M154.00
Return on Sales Growth (3y) 0.01M0.01M
Return on Sales (QoQ) 0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.01M-0.01M0.04M-75.00407.00-916.00